Close

Registration is free and only takes a moment. If you have already registered, please log in now.

Create Account
Forgot your password?
Log In
  • Links
  • Publisher Full Text
  • Publisher Full Text
  • Authors
  • Gånemo A
  • Sommerlund M
  • Vahlquist A
  • MESH
  • Adult
  • Aged
  • Female
  • Humans
  • Hypothyroidism
  • Ichthyosis, Lamellar
  • Keratin-10
  • Keratolytic Agents
  • Male
  • Middle Aged
  • Mutation
  • Pilot Projects
  • Transglutaminases
  • Tretinoin

Unbound MEDLINE

Oral alitretinoin in congenital ichthyosis: a pilot study shows variable effects and a risk of central hypothyroidism.

Links

  • Publisher Full Text
  • Publisher Full Text
  • Authors

    Gånemo A, Sommerlund M, Vahlquist A

    Source

    Acta dermato-venereologica 92:3 2012 May pg 256-7

    MeSH

    Adult
    Aged
    Female
    Humans
    Hypothyroidism
    Ichthyosis, Lamellar
    Keratin-10
    Keratolytic Agents
    Male
    Middle Aged
    Mutation
    Pilot Projects
    Transglutaminases
    Tretinoin

    Pub Type(s)

    Journal Article
    Research Support, Non-U.S. Gov't

    Language

    eng

    PubMed ID

    22278615

    Related Citations

    • Oral acitretin treatment in severe congenital ichthyosis of the neonate.
    • Lamellar ichthyosis: response to etretinate with transglutaminase 1 recovery.
    • Autosomal recessive congenital ichthyosis and congenital hypothyroidism in a Tunisian patient with a nonsense mutation in TGM1.
    • Successful treatment of harlequin ichthyosis with acitretin.
    • Compound heterozygous TGM1 mutations including a novel missense mutation L204Q in a mild form of lamellar ichthyosis.
    • Autosomal recessive congenital ichthyosis in Sweden and Estonia: clinical, genetic and ultrastructural findings in eighty-three patients.
    • Etretinate in the management of harlequin siblings.
    • High-strength tretinoin: a method for rapid retinization of facial skin.
    More
    unbound logo
    • Home »
    • Contact Us »
    • Help »
    • Privacy / Disclaimer »
    • Terms of Service »
    • Log In »
    • twitter
    • facebook
    © 2000–2013 Unbound Medicine, Inc. All rights reserved